| | | This summary is provided for our resident cucks, Brumar and Shitshatsu so they get the screening they deserve.
Whether a transgender person needs a prostate exam depends on their sex assigned at birth and any medical or surgical transitions they may have undergone:
1. Transgender women (assigned male at birth) - Yes, they may still need prostate exams.
- Even if they have undergone gender-affirming surgery (such as vaginoplasty), the prostate is usually not removed during these procedures.
- Therefore, transgender women should follow prostate cancer screening guidelines based on age and risk factors (e.g., typically starting around age 50, or earlier if there's a family history or other risk factors).
- Hormone therapy (estrogen) may shrink the prostate, but does not eliminate the risk of prostate cancer.
2. Transgender men (assigned female at birth) - No, they do not have a prostate and therefore do not need prostate exams.
Summary: - If a person has a prostate, regardless of gender identity, they may need prostate cancer screening.
- Always best to consult with a knowledgeable healthcare provider who understands transgender health to get personalized advice.
For Transgender Women (assigned male at birth): On Estrogen + Anti-androgens: - Estrogen and androgen blockers reduce testosterone levels, which are a major driver of prostate growth and prostate cancer.
- Studies show that transgender women on long-term hormone therapy tend to have a significantly lower risk of prostate cancer compared to cisgender men.
- One Dutch study (2020) found that transgender women had a 5x lower incidence of prostate cancer, likely due to testosterone suppression.
Important Caveats: - The prostate is rarely removed during gender-affirming surgery.
- Although estrogen lowers risk, prostate cancer can still occur, especially in older trans women or those not on hormones for long.
Screening Challenges: - Symptoms may be masked or misattributed.
- Rectal exams and PSA (Prostate-Specific Antigen) tests are still relevant but may be interpreted differently due to hormone effects.
Key Takeaway: - Yes, estrogen hormone therapy reduces the risk of prostate cancer.
- No, it does not eliminate the risk—trans women should still be screened appropriately if they retain their prostate.
|
|
